Related Articles Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter? Cancer. 2016 05 01;122(9):1453-60 Authors: Hamano J, Yamaguchi T, Maeda I, Suga A, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Morita T Abstract BACKGROUND: Although the place of death has a great influence on the quality of death and dying for cancer patients, whether the survival time differs according to the place of death is…
Origen: Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter? – PubMed

Related Articles Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy. Int J Oncol. 2016 Jun;48(6):2693-703 Authors: Smid D, Kulda V, Srbecka K, Kubackova D, Dolezal J, Daum O, Kucera R, Topolcan O, Treska V, Skalicky T, Pesta M Abstract MicroRNAs have the potential to become valuable predictive markers for gastric cancer. Samples of biopsy tissue, routinely taken from gastric cancer patients undergoing palliative chemotherapy, constitute suitable material for microRNA profiling with the aim of predicting the effect of chemotherapy. Our study group consisted of 54 patients, all of whom underwent palliative chemotherapy based on 5-fluorouracil (5-FU)…
Origen: Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy. – PubMed

Related Articles A Survey to Evaluate Facilitators and Barriers to Quality Measurement and Improvement: Adapting Tools for Implementation Research in Palliative Care Programs. J Pain Symptom Manage. 2017 Dec;54(6):806-814 Authors: Dy SM, Al Hamayel NA, Hannum SM, Sharma R, Isenberg SR, Kuchinad K, Zhu J, Smith K, Lorenz KA, Kamal AH, Walling AM, Weaver SJ Abstract CONTEXT: Although critical for improving patient outcomes, palliative care quality indicators are not yet widely used. Better understanding of facilitators and barriers to palliative care quality measurement and improvement might improve their use and program quality. OBJECTIVES: Development of a survey tool to assess…
Origen: A Survey to Evaluate Facilitators and Barriers to Quality Measurement and Improvement: Adapting Tools for Implementation Research in Palliative Care Programs. – PubMed

Related Articles Ultimate journey of the terminally ill: Ways and pathways of hope. Can Fam Physician. 2016 Aug;62(8):648-56 Authors: Daneault S, Lussier V, Mongeau S, Yelle L, Côté A, Sicotte C, Paillé P, Dion D, Coulombe M Abstract OBJECTIVE: To better understand the role of hope among terminally ill cancer patients. DESIGN: Qualitative analysis. SETTING: A tertiary specialized cancer centre in Canada. PARTICIPANTS: Cancer patients in palliative care with an estimated remaining life expectancy of 12 months or less (N = 12) and their loved ones (N = 12) and treating physicians (N = 12). METHODS: Each patient underwent up…
Origen: Ultimate journey of the terminally ill: Ways and pathways of hope. – PubMed

Related Articles Consideration of patient and disease characteristics in selecting radiation regimens for treatment of bone metastases. Pract Radiat Oncol. 2017 Nov – Dec;7(6):403-410 Authors: Liu Y, von Eyben R, Kidd EA Abstract PURPOSE: Radiation therapy is one of the mainstays of treatment for painful bone metastases; however, the optimal fractionation and dosing of radiation for a given patient and disease characteristics are still subject to debate. METHODS AND MATERIALS: We retrospectively examined 475 patients who received radiation for bone metastases at our institution from 2009 through 2014 and evaluated survival outcomes based on parameters of their first treatment course…
Origen: Consideration of patient and disease characteristics in selecting radiation regimens for treatment of bone metastases. – PubMed